Clinical Trial: Vascular Endothelial Growth Factor Levels in Ectopic Pregnancy

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Vascular Endothelial Growth Factor Levels in Ectopic Pregnancy

Brief Summary:

The aim of this study is to determine plasma Vascular Endothelial Growth Factor level and change in patient with ectopic pregnancy who needs to surgical treatment.

Patient with ectopic pregnancy diagnosed and treated with medically or surgically will be included in the study. This is an observational study.The plasma Vascular Endothelial Growth Factor level will be measured first day and two day after the diagnosis of ectopic pregnancy.

Detailed Summary:

This study is a prospective, observational, single-center study. Ethical approval was obtained from the Institutional Review Board. This study will be completed with 30 patients with ectopic pregnancy. An intervenous cannula will be centrifuged for 15 minutes at 1000 g within 30 minutes of collection. Aliquots of plasma will be added to eppendorf tubes and stored at -20°C.

Plasma Vascular Endothelial Growth Factor levels will be measured using a Human VEGF-A Platinum ELISA kit (bioscience company, Catalog No: 00122, Santa Clara, California, USA). All assays will be performed according to the manufacturer's instructions. The test kit sensitivity is 2.5 pg/ml. Intracycle variability is %4-6, intercycle variability is %8-10.

Sponsor: Bagcilar Training and Research Hospital

Current Primary Outcome: The primary Outcome Measure of this study is to determine plasma Vascular Endothelial Growth Factor cut-off level in patient with ectopic pregnancy who needs to surgical treatment. [ Time Frame: 3-4 months ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Bagcilar Training and Research Hospital

Dates:
Date Received: May 17, 2012
Date Started: May 2012
Date Completion:
Last Updated: August 6, 2015
Last Verified: August 2015